BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschhorn, CFO and COO, will participate in the TD Cowen 46th Annual Health Care Conference, taking place in Boston on March 3, including a fireside chat at 3:10 p.m. ET. An audio webcast of the fireside chat will be available at investors.amwell.com. About Amwell Amwell offers payers and health systems a single, comp ...

On a non-GAAP basis, HealthStream reported operating income of $6.2 million (up 31.7% ), net income of $5.4 million (up 9.5% ), and non-GAAP EPS of $0.18 , up $0.02 year over year.During the quarter, operating income fell to $2.4 million (down 48.8% ) and net income declined to $2.5 million (down 48.1% ), with diluted EPS of $0.09 versus $0.16 a year earlier. Roberts attributed much of the decline to the CEO’s contribution of $3.8 million of personally owned stock to support employee equity awards, which re ...

HealthStream (NasdaqGS:HSTM) Q4 2025 Earnings call February 24, 2026 09:00 AM ET Company ParticipantsMollie Condra - Head of Investor Relations and CommunicationsRichard Close - Managing Director of Digital and Tech-Enabled Health Equity ResearchRobert A. Frist Jr. - CEO and ChairmanRyan Daniels - Partner and Group Head of Healthcare Technology and ServicesScotty Roberts - CFO and SVP of Finance and AccountingConference Call ParticipantsConstantine Davides - Managing Director and Senior Equity AnalystMatthe ...

HealthStream (NasdaqGS:HSTM) Q4 2025 Earnings call February 24, 2026 09:00 AM ET Company ParticipantsMollie Condra - Head of Investor Relations and CommunicationsRichard Close - Managing Director of Digital and Tech-Enabled Health Equity ResearchRobert A. Frist Jr. - CEO and ChairmanRyan Daniels - Partner and Group Head of Healthcare Technology and ServicesScotty Roberts - CFO and SVP of Finance and AccountingConference Call ParticipantsConstantine Davides - Managing Director and Senior Equity AnalystMatthe ...

HealthStream (NasdaqGS:HSTM) Q4 2025 Earnings call February 24, 2026 09:00 AM ET Speaker3Good morning, and welcome to HealthStream's fourth quarter and full year 2025 earnings conference call. At this time, I would like to inform you that the conference is being recorded and that all participants are in listen-only mode. At the request of the company, we will open the conference up for questions and answers after the presentation. I would now like to turn the conference over to Mollie Condra, Head of Invest ...

Core Insights - Visionary Holdings Inc. announced progress in executing a commercial sales agreement valued at approximately US$9 million through its subsidiary, Visionary Health Technology Group Limited [1][2] - The agreement, signed in September 2025, is currently in the implementation stage with service activities underway [2][3] - The company expects to achieve further substantive execution milestones by the end of the first quarter of 2026 based on the current delivery schedule [3] Agreement Details - The commercial scope of the agreement includes the Premier Regenerative Complex product series and customized VIP health services [4] - These services are tailored based on individual health assessments and delivered within a structured medical oversight framework [4] Management Commentary - The CEO of Visionary Holdings emphasized the importance of converting strategic partnerships into operational results and highlighted the potential for revenue growth and margin improvement from this business segment [5] Company Overview - Visionary Holdings Inc. is a technology-driven multinational enterprise focused on innovative education, AI applications, and high-tech healthcare solutions, operating across North America and Asia [6]

Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion [Accessibility Statement] Skip NavigationNew Client Momentum Highlights Rapid Adoption of Marpai's Disruptive, Scalable Healthcare Platform Positioned to Drive Exponential Revenue Growth and Long-Term Shareholder ValueTAMPA, Fla., Feb. 23, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administ ...

Core Viewpoint - Piper Sandler has raised its price target on Doximity Inc. to $42 from $40 while maintaining an Overweight rating, indicating a positive outlook on the company's stock performance [1] Group 1: Doximity's AI Tool Suite - Insights from a demonstration led by CEO Jeff Tangney highlighted the strengths of Doximity's AI tool suite, particularly DoxGPT, which is noted for its integration within the Doximity ecosystem, the quality and accuracy of clinical reference responses, and a strong evidence base supporting its medical AI capabilities [2] - A new feature called PeerCheck allows healthcare professionals to efficiently transition from clinical questions to citations and original sources, enhancing the utility of DoxGPT [2] Group 2: Market Potential and Stock Valuation - As AI tools like Scribe and DoxGPT become integrated into Doximity's workflow platform, there is an expectation of increased adoption among individual healthcare professionals and enterprise contracts with hospitals and health systems, creating a virtuous cycle [3] - Piper Sandler believes the market is undervaluing DoxGPT's potential, especially following the fiscal third-quarter 2026 EPS results, leading to an updated price target of $42 based on a 20.0x multiple applied to slightly higher calendar 2027 adjusted EBITDA estimates [4]

Core Viewpoint - CareCloud, Inc. will announce its financial results for Q4 and the full year of 2025 on March 12, 2026, before market opening, followed by a conference call for investors at 8:30 a.m. Eastern Time [1]. Financial Results Announcement - The financial results will cover the fourth quarter and the full year ended December 31, 2025 [1]. - A live webcast of the conference call and related presentation slides will be available at ir.carecloud.com/events [2]. - An audio-only option for the conference call can be accessed by dialing 201-389-0920 and referencing "CareCloud, Inc. Fourth Quarter 2025 Results Conference Call" [2]. Conference Call Replay - A replay of the conference call and related presentation slides will be available approximately three hours after the call concludes at the same link [3]. - An audio-only option for the replay can be accessed by dialing 412-317-6671 and providing the access code 13758591 [3]. Company Overview - CareCloud specializes in AI-powered healthcare technology and revenue cycle management solutions, serving over 45,000 providers [4]. - The company's solutions aim to enhance financial and operational performance, streamline clinical workflows, and improve patient experience [4]. - CareCloud offers a range of products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM), and digital health [4].

Core Insights - HEALWELL AI Inc. and WELL Health Technologies Corp. have launched WELLTRUST™, a platform designed for secure, consent-driven patient identification for clinical research within WELL-operated clinics in Canada [1][10]. Company Overview - HEALWELL AI focuses on preventative care through healthcare artificial intelligence, aiming to improve healthcare outcomes by early disease detection and clinical decision support systems [7]. - WELL Health Technologies aims to empower healthcare providers through technology, operating over 240 clinics in Canada and serving more than 43,000 healthcare providers across North America [8]. Platform Features - WELLTRUST accelerates clinical research recruitment by allowing patients to consent to future outreach for clinical trials, combining WELL's clinical footprint with HEALWELL's AI capabilities [2][10]. - The platform provides a privacy-preserving infrastructure that enables ethical patient identification and research acceleration while allowing patients to opt-out if they choose [2][11]. - WELLTRUST includes a robust governance and compliance framework to meet Canadian privacy standards, facilitating partnerships with pharmaceutical sponsors and research organizations [11]. Leadership Commentary - Dr. Alexander Dobranowski from HEALWELL emphasized the platform's commitment to responsible AI in healthcare, aiming to enhance patient access to innovations while maintaining privacy [3]. - Dr. Michael Frankel from WELL highlighted the importance of technology in improving healthcare outcomes and empowering patients to participate in research safely [5].